BioImagene logo

BioImagene

37 employees · est. 2003 · Sunnyvale, United States

VS
OptraSCAN logo

OptraSCAN

A global leader, advancing digital pathology through AI technology for improved precision, efficiency, and patient care

39 employees · est. 2015 · San Jose, United States

BioImagene is the older company (2003 vs 2015).

Side-by-Side Comparison

BioImagene OptraSCAN
Founded
2003 older 2015
Headquarters
Sunnyvale, United States San Jose, United States
Employees
37 39
Industry
Biotechnology, Health Care Health Care, Medical Devices
Funding Stage
Series D Not tracked yet
Total Funding
$30.20M Not tracked yet
Funding Rounds
2 Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Diagnosis Solutions, Tissue-based Diagnostic, Digital Pathology, Automated Staining, Patient Reports, Image Analysis, Information Management, Clinical Labs, Pathology Workflow, Efficiency Improvement, Medical Centers, Hospitals, Laboratories, Pharmaceutical Industry Digital Pathology, AI In Pathology, Whole Slide Scanners, Pathology Lab Solutions, Histology Slide Scanner, Telepathology, Cloud-Based LIMS, Image Analysis Tools, Computer-Aided Region Detection, AI-Powered Diagnostics, Pathology Imaging Technology, Precision Pathology Solutions, Workflow Optimization In Pathology, Remote Image Viewing
Website
bioimagene.com optrascan.com
BioImagene logo

About BioImagene

BioImagene is a biotechnology and healthcare startup, founded in 2003 and headquartered in the United States. Acquired by Ventana Medical Systems in August 2010, it has since been a key player in delivering tissue-based diagnostic solutions for patients globally. The $26.00M Series D investment in A...

OptraSCAN logo

About OptraSCAN

OptraSCAN, founded in 2015, is a global leader in digital pathology, specializing in advanced technology aimed at revolutionizing diagnostics and patient care. The company offers cutting-edge digital pathology solutions, including brightfield slide scanners, histology slide scanners, and fluorescenc...

We will tell you when either one moves

BounceWatch watches BioImagene and OptraSCAN for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at BioImagene and OptraSCAN — by email.

Frequently Asked Questions

BioImagene. OptraSCAN — A global leader, advancing digital pathology through AI technology for improved precision, efficiency, and patient care. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
BioImagene has raised $30.20M while OptraSCAN has raised undisclosed funding.
BioImagene and OptraSCAN operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare BioImagene with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at BioImagene on 11 Sep 2024, and OptraSCAN on 28 Oct 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy